Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
1228.HK
CANbridge Pharmaceuticals Inc.
HKSE
Biotechnology
China
HK$1.92
▼
-0.01 (-0.52%)
INTL
—
OPEN
HK$1.93
HIGH
HK$1.96
LOW
HK$1.90
PREV CLOSE
HK$1.93
VOLUME
716.0K
0.36x avg
BID / ASK
1.90 / 1.93
spr 0.030
MARKET CAP
HK$1.15B
DAY RANGE
HK$1.90
HK$1.96
P/E (TTM)
—
EPS (TTM)
-0.21
DIV YIELD
—
52W HIGH
HK$3.50
-45.1%
52W LOW
HK$1.61
+19.3%
BETA
-0.12
vs S&P 500
DES
FA
GP
HLDR
EARN
CMP
COMPARE
ASK DESK
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
1228.HK
HK$1.92
▼
-0.52%
Chart
Valuation
Financials
Peers
News
1228.HK · K 線技術分析（即時、可互動）
basic
pro
快速分析（約半分鐘，最長 5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，通常約半分鐘，上游壅塞時最長 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
RISK-OFF
246 BARS · -13.1% YOY
1-year price chart. Started at 2.21, currently 1.92, down 13.1 percent. Range 1.67 to 3.15 over 246 data points.
2025-09-04
$2.21 → $1.92 (-13.1%)
2026-09-04
§ Valuation
Loading § Valuation
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
—
WACC Used
+7.0%
Terminal g
+3.5%
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers. · Comparables skipped: no peer multiples or no per-share economics from Finnhub metric endpoint.
NEWS
近期新聞（過去 14 天）
CALM
10 HEADLINES · LAST 14 DAYS
Kalshi, Polymarket bets are big problem for NFL
TheStreet · 2026-09-05
A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?
Barrons.com · 2026-09-05
In HelloNation, Plumbing Expert Jared Voss Explains When Water Heater Noises Point to a Bigger Problem
PR Newswire · 2026-09-05
Olympic champion Zheng storms home to reach US Open last 16
AFP · 2026-09-05
Extended Strategic Agreements to Support Management’s Full-Year 2026 Guidance Raise for ATI Inc. (ATI)
Insider Monkey · 2026-09-05
High-Yield Dividend Investors Could Be Making This Expensive Tax Mistake
24/7 Wall St. · 2026-09-05
Jim Cramer Shares His Playbook for Buying Applied Materials (AMAT)
Insider Monkey · 2026-09-05
Office Sales Jump 31% as CBD Transactions Accelerate
CRE Daily · 2026-09-05